Comparison

Evifacotrep European Partner

Item no. HY-132813-5mg
Manufacturer MedChem Express
CASRN 2413739-88-3
Amount 5 mg
Category
Type Inhibitor
Specific against other
Purity 99.55
Formula C18H12ClF4N5O2
Citations [1]WO2020061162
Smiles O=C1NN=CC(N2CC3=C(CC2)C(OC4=CC=C(C=C4C(F)(F)F)F)=NC=N3)=C1Cl
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
Evifacotrep, a short transient receptor potential channel 5 and 4 (TRPC5/TRPC4) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases. Evifacotrep targets to TRPC5/TRPC4 with IC50s ≤50 nM[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Neuroscience-Neuromodulation
MolecularWeight
441.77
Clinical_Information
No Development Reported
Manufacturers Research_Area
Neurological Disease
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target
TRP Channel
Pathway
Membrane Transporter/Ion Channel; Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close